Isembyld® (apitegromab-mstn)
| Full Name | Isembyld™ (apitegromab-mstn) |
| Drug | apitegromab |
| Manufacturer | Scholar Rock |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | The treatment of spinal muscular atrophy (SMA) in adults and pediatric patients 2 years of age and older who are currently receiving a survival motor neuron 2 (SMN2)-targeted treatment |
| Disease | Spinal muscular atrophy (SMA) |
| Therapeutic Area | Neurology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | 888-221-4943 |
| Fax Number | 847-892-1205 |
| Website | isembyldhcp.com |
| Patient Resources | Cure SMA and Muscular Dystrophy Association |